Attached files
| file | filename |
|---|---|
| 8-K - China Polypeptide Group, Inc. | v173467_8k.htm |
Exhibit 16.1
February 8, 2010
Securities and Exchange
Commission
100 F Street, N.E.
Washington DC
20549-7561
|
Re:
|
China Polypeptide Group, Inc. (f/k/a
Hamptons Extreme, Inc.)
|
File No. 333-151148
Commissioners:
We have read Item 4.01 of Form 8-K dated
February 8,
2010, of China Polypeptide Group, Inc. (f/k/a Hamptons
Extreme, Inc.) and are in
agreement with the statements contained therein insofar as they relate to our
dismissal and our audits for the year ended December 31, 2008 and 2007 and our reviews of interim financial
statements. We are not in a position to agree or
disagree with the statements contained therein in Item 4.01 regarding the
engagement of another independent registered public accounting firm or the
approval of such engagement by the Board of Directors of the
registrant.
/s/Li & Company,
PC
Li & Company, PC